STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.
The Pig-A gene plays a pivotal role in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, which tether a multitude of proteins to the cell surface. Mutations in this X‐linked gene result ...
Integration of GenEvolutioN’s Best-in-Class Micronucleus Genotoxicity screen strengthens 3RnD as a unified digital ...
Powered by gene editing advances like CRISPR and base editing, cell and gene therapy (CGT) is delivering on the promise of genomic medicine. First-generation CAR T-cell therapies, for example, have ...
Integration of the Xenometrix Ames mutagenicity test modernizes this cornerstone, regulatory-aligned NAM within the ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...
Several noteworthy changes are anticipated in a new FDA guidance document on biological evaluation and biocompatibility testing of medical devices due out sometime this year. Audrey Turley There has ...
The research is published in the Journal of Toxicology and Environmental Health and considers the DNA damage of sucralose, the sweetener, and its metabolite, sucralose-6-acetate.
NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ — STEMart, a US-based provider of comprehensive services for all phases of medical device ...